Lidocaine 1%
Lidocaine 1% is a pharmaceutical drug with 7 clinical trials. Currently 1 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
2
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
75.0%
3 of 4 finished
25.0%
1 ended early
1
trials recruiting
7
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Intralipid® 20% for Reversal of Local Anesthetics
Prospective Clinical Analysis of Ultrasound-guided Biceps Corticosteroid Injections
Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Bariatric Surgery
Psoas Sciatic Blockade for Knee Arthroplasty
Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy
Clinical Trials (7)
Intralipid® 20% for Reversal of Local Anesthetics
Prospective Clinical Analysis of Ultrasound-guided Biceps Corticosteroid Injections
Perioperative Systemic Lidocaine for Enhanced Bowel Recovery After Bariatric Surgery
Psoas Sciatic Blockade for Knee Arthroplasty
Combined Intravenous Diazepam, Local Periprostatic Nerve Block for Prostate Biopsy
Use of Lidocaine in Endoscopic Submucosal Dissection
Lidocaine-Prilocaine Cream (EMLA) Topical Application Versus Wound Infiltration With Lidocaine After Cesarean Section
All 7 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 7